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ABSTRACT 
 
Background:  Maternal caffeine consumption during pregnancy directly affects the 
developing fetus as caffeine is rapidly absorbed in the maternal gastrointestinal tract and 
freely passes across the placenta.  There is much concern about the affect of caffeine on 
reproductive outcomes prior to pregnancy and increased rates of fetal death.  Since the 
1980s, numerous studies have been published on caffeine intake during pregnancy and 
the risk of miscarriage and stillbirths.  However, a clear consensus on whether caffeine 
posses these risks has yet to be determined.  A systematic review of the literature using 
the Grading of Recommendations Assessment, Development and Evaluation (GRADE) 
tool developed by the GRADE Working Group will be conducted to determine an 
accepted conclusion to this topic.   
 
Method:  An exhaustive search of available medical literature was conducted using the 
following databases; Medline, PubMed, Cochrane Systematic Reviews, and CINAHL.   
 
Results:  A total of five studies, four cohort and one case-control, were reviewed in their 
entirety.  These studies looked at the relationship between caffeine intake during 
pregnancy and its proposed associations to an increase risk of miscarriage and stillbirth 
rates. 
 
Conclusion:  Based on the combined results there is still much uncertainty.  Four studies, 
all demonstrate a dose-response related effect on caffeine and negative pregnancy 
outcomes.  Only one study did not show a relationship between caffeine and miscarriages 
or stillbirths.  The final GRADE for this review is moderate.  
 
Keywords:  Miscarriage, spontaneous abortion, caffeine 
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INTRODUCTION 
Background 
Caffeine (1,3,7-Trimethylxanthine) is the most widely consumed 
pharmacologically active substance in the world (Weng, Odouli, & Li, 2008).  Due to 
these high consumption rates, caffeine is one of the most commonly researched topics 
drawing much attention to its affects on human health.  The US Food and Drug 
Administration (FDA) first claimed caffeine to be potentially harmful for pregnant 
females on September 5, 1980.  The FDA issued its warning, which was based primarily 
on animal studies, to avoid or restrict caffeine intake during pregnancy (Giannelli, Doyle, 
Roman, Pelerin & Hermon, 2003).  Many people today believe that caffeine is linked to 
various health conditions and is perceived by many to be harmful to health.  There is 
much concern about the affect of caffeine on reproductive outcomes such as; increased 
rates of miscarriage, congenital malformations, fetal growth restrictions, stillbirths, long-
term behavioral issues, and decreased fertility (Norman & Nisenblat, 2011).   
Epidemiological studies on this topic have produced conflicting results.  Currently, few 
studies report no association between caffeine consumption and negative fetal outcomes 
while numerous studies show either weak or strong associations (Greenwood et al. 2010). 
Caffeine can be found in numerous beverages and foods including; coffee, tea, 
cola, soft drinks, energy drinks, and chocolate.  Caffeine is also added to certain 
prescriptions and over-the-counter medications, such as cold, flu, allergy, and headache 
treatments, diet pills, diuretics, and stimulants.  Coffee which contains fifty to seventy 
percent more caffeine than other products, is the main source of caffeine intake (Norman 
& Nisenblat, 2011).   In the United States’ general population, the prevalence of caffeine 
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exposure is greater than 80%.  In 2005, the United States Department of Agriculture 
reported that 89% of women ages 18 to 34 consume caffeine with an average daily intake 
of 164 mg per day.  Even though most women reduce their caffeine consumption during 
pregnancy, average daily intake among pregnant females still remains at 125 mg.  
(Bakker, Steegersw, Obradov, and Raat, 2010; Norman & Nisenblat, 2011; Anderson, 
Juliano & Schulkin, 2009).    
 Animal studies looking at caffeine’s effect on birth outcomes, have confirmed that 
caffeine intake is associated with increased rates of malformations and decreased fetal 
weights in rodents, as well as increased rates of miscarriages and stillbirths in monkeys.  
The relevance of these animal studies is unclear as the pharmacokinetics of caffeine 
differs between animals and humans (Fenster et al. 1997).  However, previous studies 
looking at the effects of caffeine on pregnancy outcomes in humans, have linked high 
maternal caffeine intake to small for gestational age or low birth weight infants.  (Bech et 
al., 2007).    
Controversy on the link between caffeine intake and miscarriage or stillbirths still 
remains as prior studies show varying results.  These inconsistent results could possibly 
be due to differing factors in the study design, number of subjects, methods of obtaining 
accurate caffeine intake, and adjustment for potential confounders (Bakker et al. 2010).   
Numerous studies have shown a correlation between women with high caffeine 
consumption during pregnancy and those with higher levels of smoking and alcohol 
intake, and lower educational levels (Bech et al. 2007).  This association further 
complicates the study outcomes as results can be distorted by these confounding factors.   
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Many studies are now taking into account several potential confounders and effect 
modifiers.  Even so, the effect of caffeine intake during pregnancy still remains unclear.    
Maternal caffeine consumption during pregnancy directly affects fetal caffeine 
levels as caffeine is rapidly absorbed in the maternal gastrointestinal tract and freely 
passes across the placental barrier as well as the blood brain barrier  (Bech et al. 2007; 
Giannelli et al. 2003).   Bech et al, (2007), reports that caffeine’s effects include an 
increase in catecholamine levels and cyclic adenosine monophosphate, cAMP.  This 
increase in the release of circulating catecholamines from the renal medulla has been 
associated with uteroplacental vasoconstriction and fetal hypoxia which can lead to 
altered fetal growth and possible death.  The authors also report that caffeine prevents 
cyclic nucleotide phophodiesterases which results in an increase in cAMP.  High levels of 
cellular cAMP may interfere and influence fetal cell development and growth.  Caffeine 
also has an effect on the fetal cardiovascular system which can lead to tachycardia and 
other arrhythmias (Wisborg et al., 2003).  Increased fetal breathing activity has also been 
identified (Bech et al., 2007).  Some evidence points to caffeine producing chromosomal 
aberrations in human cells but no studies have confirmed this (Giannelli et al. 2003; 
Norman and Nisenblat, 2011).   As a result, most guidelines recommend limiting caffeine 
intake immediately before and during pregnancy as a precaution (Greenwood et al., 
2010). 
Caffeine is metabolized in the liver by the cytochrome P450 family of enzymes, 
with cytochrome P450 1A2 being the predominant enzyme.  CYP1A2 metabolizes 
caffeine through a demethylation process (Norman & Nisenblat, 2011).  The half life of 
caffeine ranges from 4.1 to 6.4 hours in a non-pregnant female but during pregnancy this 
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half life increases due to hormonal changes.  In the first trimester, caffeine’s half life 
increases to approximately 10 hours and again increases to 18 hours during the third 
trimester.  This can lead to elevated caffeine levels among women who maintain their 
usual caffeine intake or even slightly decrease their consumption.  Elevated levels of 
caffeine in pregnant females can produce intoxication symptoms such as nervousness, 
jitteriness, and cardiac arrhythmias.  An increase in fetal exposure to caffeine may also 
occur (Anderson, Juliano & Schulkin, 2009; Bech, Obel, Henriksen, & Olsen, 2007; 
Norman & Nisenblat, 2011).   Caffeine metabolism in fetuses and neonates is 
exceedingly slow with an 80 to 100 hour half life due to a lack of CYP1A2 enzymes.  
This is due to the immature liver systems in the fetus and neonate which do not fully 
develop until 6 to 8 months after delivery (Anderson, Juliano & Schulkin, 2009).  
Therefore, even low maternal caffeine consumption will lead to increased and prolonged 
levels of fetal exposure (Bakker et al., 2010; Giannelli et al., 2003; Norman & Nisenblat, 
2011).   
Maternal exposure to caffeine is not based solely on intake but also on the rate of 
caffeine metabolism and clearance from the body.  Individuals are classified as either 
slow or fast metabolizers with caffeine metabolism rates depending on various genetic 
and environmental factors.  The main factors are CYP1A2 activity, cigarette smoking, 
pregnancy, oral contraceptives, liver disorders, various medications, and ethnicity.  The 
variation in metabolism rates among pregnant women could be a factor in determining 
the fetus’s susceptibility to the effects of caffeine.  Further studies and data on these 
factors are needed in order to validate their influence on the risk of pregnancy loss and 
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other negative pregnancy outcomes (Anderson, Juliano & Schulkin, 2009; Signorello et 
al., 2001).   
Since the 1980s, a number of studies have been published on maternal caffeine 
intake during pregnancy and the risk of miscarriage and stillbirths.  However, a clear 
consensus on whether caffeine posses these risks has yet been determined (Signorello & 
McLaughlin, 2004).   
 
Purpose of the Study 
The purpose of this systematic review is to summarize the epidemiological 
evidence and results found in five separate cohort and case-control studies in order to 
come to an accepted conclusion on this topic of great interest and importance.  In addition 
the methodological issues that have impaired the interpretation of previous studies will 
also be discussed in order to determine how future studies can be improved to gain 
additional information on this topic of immense controversy and debate.  A systematic 
review of the literature looking at the effects of caffeine consumption in pregnant women 
and the risk of miscarriage or stillbirth using the Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) tool developed by the GRADE 
Working Group will be performed (Guyatt et al., 2008). 
 
 
 
METHOD 
 
An extensive literature search was performed using Medline, PubMed, Cochrane 
Systematic Reviews, and CINAHL.  These databases were accessed through the Pacific 
University Library system.  The following keywords were searched individually and in 
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combination: miscarriage, spontaneous abortion, and caffeine.  This initially resulted in 
1,013 articles.  The search was limited to human studies, English language, and articles 
published since 2005.  This resulted in 135 articles to be reviewed, the CINAHL database 
alone identified 102 articles of the total 135.  After hand searching through the articles in 
the CINAHL database, it was determined that one article was relevant for the systematic 
review.  The remaining 33 artilces were also hand-searched.  Articles that did not 
investigate caffeine’s effect on miscarriage and stillbirth rates were excluded.  This 
resulted in five studies, four cohort and one case-control, for the final systematic review 
which were retrieved from Medline, PubMed, CINAHL, and Cochrane Systematic 
Reviews.    
 
RESULTS 
 
Caffeine Intake During Pregnancy, Late Miscarriage and Stillbirth, Written by 
Greenwood et al., (2010) 
 
The purpose of this cohort study was to examine the relationship between caffeine 
consumption and miscarriage or stillbirth rates.  This study was performed in two 
separate maternity units in the United Kingdom between September 2003 and June 2006.   
Study participants included 2,643 women ages 18 through 45 with singleton pregnancies.  
These women entered the study between 8 and 12 weeks of gestation.  Women with prior 
chronic disease, psychiatric illness, HIV, or hepatitis B infections were excluded from 
this study.   
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The authors used a validated and highly detailed caffeine assessment tool to 
calculate total caffeine consumption.  Women were given this caffeine assessment to 
track their caffeine intake at specific time periods throughout their pregnancy: 4 weeks 
before pregnancy, weeks 1 through 4, 5 through 12, 13 through 28, 28 through 36, and 
finally at the end of their pregnancy.  The questionnaire looked at all possible dietary 
sources of caffeine; food, drink, and over-the-counter medications.  Specific brand 
names, portion sizes, methods of preparation, quantity and frequency of intake were all 
obtained.  Caffeine intake was then calculated based on the published caffeine content for 
each item and from information provided by manufacturers and coffee houses.  This 
study tried to correct for potentially important confounders by including alcohol intake, 
tobacco use, nausea, and vomiting in their questionnaire.     
The primary outcomes were defined as spontaneous pregnancy loss, occurring 
between 12 and 24 weeks of gestation, and stillbirth, occurring at or after 24 weeks.  
Caffeine intake was measured in milligrams per day, mg/day.  The authors examined 
caffeine consumption during each trimester in order to determine when caffeine 
consumption has the largest effect on pregnancy outcomes.   Caffeine consumption 
during the second and third trimester was too small to investigate any associations.  The 
first trimester was divided into (1) 4 weeks prior to the pregnancy (2) weeks 1-4, and (3) 
weeks 5-12.  Median caffeine intake during the 4 weeks prior was 217 mg/day (104-366).  
Median caffeine intake over the first 4 weeks was 183mg/day (74-321).  Median caffeine 
intake over weeks 5-12 was 92 mg/day (22-217).  Over the entire first trimester, the 
median caffeine intake was 132mg/day (58-241).     
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Among women who had live births, their average caffeine intake was 103 mg/day 
(95% CI: 98-108).  For women who had stillbirths or miscarriages, their average caffeine 
intake was 145 mg/day (95% CI: 85-249).  The authors reported all findings after 
adjustments were made for maternal age, parity, alcohol intake, and tobacco use.  When 
compared to caffeine intake of less than 100 mg/day, the odds ratio for miscarriages or 
stillbirths increased to 2.2 (95% CI: 0.7-7.1) for intakes between 100-199 mg/day, to 1.7 
(95% CI: 0.4-7.1) for intakes between 200-299mg/day, and finally to 5.1 (95% CI: 1.6-
16.4) for intakes of 300 + mg/day.  Results were unchanged after adjusting for nausea, 
Index of Multiple Deprivation, for previous deliveries, and tobacco use.  (Appendix A, 
Table 1). 
This study demonstrates a positive correlation between increased caffeine intake 
during pregnancy and late miscarriages and stillbirths.  Consumption of 300 mg or more 
of caffeine per day has been shown to increase miscarriage rates up to 5 times that of 
women with no caffeine consumption.  Based on the following results, the authors state 
that greater caffeine intake is associated with increases in late miscarriage and stillbirth.   
 
 
Maternal Caffeine Consumption During Pregnancy and the Risk of Miscarriage: 
A Prospective Cohort Study, Written by Weng et al., (2008) 
 
This prospective cohort study was conducted to determine the risk association 
between miscarriage and caffeine intake.  The study was performed at the Kaiser 
Permanente Medical Care Program in San Francisco between the dates of October 1996 
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and October 1998.  Pregnant females residing in the San Francisco area were identified as 
being potential candidates.  Inclusion criteria consisted of intention to carry the 
pregnancy to term, English speaking, and those who did not return the refusal card to 
participate.  Women who were greater than 15 weeks along in their pregnancy and those 
already included in the study for one pregnancy were not eligible to be included for 
subsequent studies.  Of the initial 2,729 eligible pregnant females, 1,063 (39% of the total 
eligible) completed the interview.  
Information on exposure to caffeine was gathered during an in-person interview 
which was conducted soon after the pregnancy was confirmed, with an average of 71 
days of gestation.  Information on the frequency and amount of intake of coffee, tea, and 
caffeinated soda consumption since the last menstrual period was collected.  Women 
were also asked if their consumption pattern had changed since becoming pregnant and, 
if so, information on the new frequency and amount of intake was gathered.  The average 
daily intake was then calculated.  Information was also gathered on potential 
confounders; maternal age, race, education, household income, marital status, alcohol 
consumption, smoking, hot tub use, exposure to magnetic fields, and symptoms related to 
pregnancy such as nausea and vomiting.  This study only looked at pregnancy outcomes 
up to 20 weeks of gestation because by definition a miscarriage is a fetal death happening 
at or before 20 weeks gestation.  A fetal death occurring after 20 weeks is defined as a 
stillbirth.  Pregnancy outcomes were obtained by searching through inpatient or 
outpatient databases, reviewing medical records, or contacting the participant if the 
outcome could not be determined by using the previous two methods. 
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The average daily caffeine intake during the pregnancy was categorized as 0, less 
than 200mg/day, or greater than 200 mg/day.  Of the 1,063 women, 264 women (25%) 
reported no caffeine consumption, 635 women (60%) reported 0-200 mg/day of caffeine 
intake, and 164 (15%) reported greater than 200 mg/day.  Compared to nonusers, women 
who consumed 0-200 mg daily had an increased risk of miscarriage (15% to 12%) and 
the risk was much greater (25%) among women who consumed more than 200 mg daily.  
These results show an increase miscarriage risk with increased caffeine consumption.  
After adjustment was made for potential confounders, the hazard ratio of miscarriage was 
1.42 (95% CI, 0.93 to 2.15) for daily caffeine consumption of 0-200 mg and 2.23 (95% 
CI, 1.34 to 3.69) for consumption of 200 mg or more, p for trend < .01.  Similar results 
were seen among women with and without nausea and, or vomiting. The effect of 
caffeine consumption on miscarriage was higher in the nonsmoker group (adjusted 
hazard ratio[aHR] 2.04, 95% CI, 1.35 to 3.09) than the smoker group (aHR 1.49, 95% CI, 
0.36 to 6.08).  In addition, caffeine’s effect on the risk of miscarriage was stronger among 
women without a history of miscarriage (aHR 2.33, 95% CI, 1.48 to 3.67).  There was no 
association among women with a history of previous miscarriage (aHR 0.81, 95% CI, 
0.34 to 1.94).  (Appendix A, Table 2).  
A positive correlation between caffeine intake during pregnancy and late 
miscarriages and stillbirths was demonstrated in this study.  The results of this study 
show that increasing amounts of caffeine are associated with increased risks of fetal death 
especially at intakes of 200 mg or more per day.  At these levels, the risk of miscarriage 
is two times higher compared to women with no caffeine intake.  Based on these 
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conclusions, the authors recommend limiting or stopping caffeine intake during 
pregnancy.   
 
 
Caffeine and Miscarriage Risk, Written by Savitz et al., (2008) 
 
This study was performed in Galveston, Texas; Memphis, Tennessee; and Raleigh, 
North Carolina and published in January 2008.  Information on possible participants was 
obtained through public and private prenatal care providers.  Pregnant females at less 
than 12 weeks’ gestation and 18 years of age or older were eligible to participate.  
Women between the ages of 18 and 45 who had been trying to conceive for over 6 
months were identified and enrolled if they became pregnant.  This resulted in 2,407 
pregnant female subjects.   
The women were contacted by telephone prior to 16 weeks’ gestation.  They were 
interviewed regarding their daily caffeine intake and any changes in their consumption 
over the perinatal period. Information about alcohol, drugs, and cigarette usage, water 
exposure, medical history, and reproductive history were also gathered at this time.  The 
women were asked about caffeinated, brewed and instant, coffee; caffeinated, iced and 
hot, tea; and caffeinated soda consumption per day.  They assigned cups of coffee and hot 
tea as being small (4-10 oz), medium (12-14 oz), or large (16-24 oz).  A cup of iced tea 
was defined as being small (4-10 oz), medium (12-20 oz), or large (22-34 oz).  Soda was 
categorized as being small (8-12 oz), medium (14-22 oz), or large (24-34 oz).  The 
caffeine content was determined using the midpoint of the cup size.  Changes in 
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consumption, including the amount and timing of any changes were also obtained.  92% 
of women reported a change in their normal caffeine intake during pregnancy. 
The women were followed from the day of enrollment up to 20 weeks’ gestation.  
Pregnancy outcomes, which consisted of pregnancy survival, miscarriage, or loss to 
follow-up, were identified during the follow-up interview and were confirmed by medical 
records or by vital records.  A miscarriage was defined as loss of a clinically recognized 
pregnancy at or before 20 weeks’ gestation. Among the 2,407 females in the study, 258 
(10.7%) miscarriages were reported.  Caffeine and coffee consumption were divided into 
3 groups: none, less than median, greater than median.  This study also compared those  
with caffeine intake in and above the 75th percentile to those who consumed none.   
Potential confounders were taken into consideration when results were calculated 
and included maternal age, race/ethnicity, education, marital status, income, smoking, 
alcohol use, body mass index, age at  menarche, employment status, diabetes, miscarriage 
history, induced abortion history, vitamin use, and nausea and vomiting in early 
pregnancy.  After adjustments were made for nausea and vomiting, no differences in the 
results were shown. 
At the time of the interview, caffeine intake was divided into 0 mg/day, 0-144.3 
mg/day, greater than 144.3 mg/day, and greater than 273.2 mg/day.  The odds ratio and 
95% confidence intervals are as follows; 1.0; 0.9 (95% CI 0.6-1.4); 1.1 (95% CI 0.7-1.7); 
1.1 (95% CI 0.6-1.8) for the previously stated amounts of caffeine intake.  (Appendix A, 
Table 3).   
Based on the results of this study, the authors conclude that caffeine consumption 
is not related to miscarriage rates.   
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Coffee and Fetal Death: A Cohort Study with Prospective Data, Written by Bech 
et al. (2005) 
 
The intention of this study was to evaluate the relationship between coffee 
consumption during pregnancy and the risk of miscarriage.  This prospective cohort study 
was performed in Denmark within the Danish National Birth Cohort from March 1996 to 
November 2002 and published in June of 2005.  Women were recruited to the Danish 
National Birth Cohort by their general practitioner.  Pregnant females were informed of 
this study at their first antenatal visit which fell between week 6 to 10 of gestation and 
approximately 60% of all eligible women choose to participate.  The inclusion criteria 
consisted of; being accessible by telephone, being able to speak Danish, and the intention 
to continue their pregnancy until term, resulting in 88,570 total participants.   
 Information on various exposures during pregnancy was collected through 
computer-assisted telephone interviews which took place at approximately 16 weeks’ 
gestation.  The exposure of interest was coffee.  Participants were asked about the 
number of cups of coffee that they consumed in a day.  In the analysis, coffee intake was 
measured in numbers of cups consumed per day; 0, ½–3, 4–7, and more than 8 cups/day.  
100 mg of caffeine was assigned per cup of coffee and 50 mg for a cup of tea.  They were 
also asked about cups of tea consumed daily and amount of soda consumed in a week’s 
time, none, less than 1 liter, or more than 1 liter per week.  Information on potential 
confounders, such as previous fetal death, parity, smoking, alcohol intake, height, pre-
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pregnancy body weight, and socio-occupational status, was also collected in the first 
interview.   
 The main outcome in the study was fetal death, defined as either spontaneous 
abortion (gestational age <196 days) or stillbirth (gestational age greater than or equal to 
196 days).  Birth outcomes were identified in the Civil Registration System and the 
Danish Medical Birth Registry.  The follow-up period was divided into three gestational 
age intervals <140 days, 140–195 days, and greater than or equal to 196 days to study 
whether coffee increased the risk of fetal death during a specific time period.  A total of 
49,042 (55.4 %) women reported no coffee consumption during pregnancy; 27,803 
women (31.4 %) drank ½–3 cups/day, 8,619 women (9.7%) drank 4–7 cups/day, and 
3,018 women (3.4 %) drank more than 8 cups/ day. Among the 88,482 pregnancies, 
1,102 fetal deaths were reported.  According to the results, there was an elevated risk of 
fetal death based on coffee consumption with the risk increasing based on the number of 
cups of coffee consumed.  Compared with females who did not consume coffee, the 
adjusted hazard ratios for fetal death associated with coffee consumption of 1/2–3 cups, 
4–7 cups, and greater than or equal to 8 cups of coffee per day were 1.03 (95% CI: 0.89- 
1.19), 1.33 (95% CI: 1.08-1.63), and 1.59 (95% CI: 1.19- 2.13), respectively.  Those who 
consumed eight or more cups of coffee per day had twice the risk of miscarriage or 
stillbirth compared to women who did not drink coffee.  After adjustment for potential 
confounders, the risk was still present and remained high (HR = 1.59, 95% CI: 1.19-
2.13).  (Appendix B, Table 4).   
 The results of this study show a positive dose-response effect on coffee intake 
during pregnancy with higher rates of miscarriage.  Compared to women with no coffee 
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consumption, consumption of more than 8 cups per day is associated with an increase in 
fetal death of over 1.5 %.  Therefore based on these results, the authors of this study 
recommend limiting coffee intake to 3 or less than cups per day while pregnant.    
 
 
Maternal Caffeine Consumption and Fetal Death: A Case-control Study in 
Uruguay, Written by Matijasevich et al. (2006) 
 
The purpose of this study was to investigate the link between caffeine consumption 
during pregnancy and fetal mortality.  This was the only case-controlled study in this 
systematic review.  This population-based study was conducted between August 1, 2002 
and December 31, 2003, and took place in Montevideo, Uruguay.  A total of 1,174 
pregnant females were involved in this study, 792 in the control group and 382 in the 
case group.  The controls were women who had a live, vigorous and term adequate-for-
gestational-age newborn.  Cases were women with a confirmed diagnosis of spontaneous 
fetal death of at least 20 weeks’ gestational age.  Multiple gestations and fetuses or 
newborns with congenital malformations were excluded from this study.   
  
The main sources of caffeine in South America are from coffee and mate 
drinking, and so caffeine intake was estimated from these two sources.  Mate drinking is 
a common South American drink prepared from steeping dried leaves of yerba mate in 
hot water.  For coffee and mate drinking, daily intake was obtained for each trimester 
using a questionnaire.  The questionnaire also collected information on the following 
variables, some of which are potential confounders: maternal anthropometric measures, 
marital status, family income, crowding, level of education of the mother and her partner, 
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mother’s age, smoking during pregnancy, prenatal care attendance, obstetric history and 
morbidity during pregnancy. Information about birth weight, sex and causes of death 
were obtained from maternal and newborn hospital records. 
Interviews were conducted during the first twenty-four hours after birth by trained 
medical students.  Information was collected on the usual method of preparation, the size 
of the serving, and the reported strength of the beverage.  Daily caffeine intake was 
calculated by trimester and throughout the entire pregnancy.  Women who did not 
consume caffeine during pregnancy made up the control group.   Women who consumed 
0- 300 mg of caffeine per day made up the case group with consumption of 300 mg of 
caffeine or more making up the highest category.   
This study was made up of 1,174 pregnant females with 792 (67.4%) live births 
and 382 (32.6%) fetal deaths.  Based on the results, caffeine intake during pregnancy was 
significantly associated with fetal mortality (P > 0.001), and a dose–response effect of an 
increased risk of fetal death with higher caffeine intakes during pregnancy was observed.  
After controlling for possible confounders, the mean caffeine intake of 300 mg/day or 
more showed a significantly increased risk of fetal death OR 2.33 95% CI 1.23; 4.41 
compared with no caffeine consumption during pregnancy.  (Appendix B, Table 5). 
The women in the case group consumed more caffeine than the women in the 
control group.  Only a small proportion of the mothers (8.1% of the cases and 9.5% of the 
controls) did not consume caffeine during pregnancy.  After controlling for all potential 
confounders, caffeine intake remained significantly associated with fetal death (P trend > 
0.001).    
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The results of this study demonstrate that consuming more than 300 mg of 
caffeine per day is associated with an almost 2.5 time increase in fetal death compared to 
women with no caffeine consumption.  Based on the results of this study, the authors feel 
that caffeine is a preventable risk factor and therefore should be limited or avoided during 
pregnancy.   
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DISCUSSION 
 Based on the combined results from the five previously conducted studies, which 
looked at the relationship between caffeine intake during pregnancy and its proposed 
associations to an increased risk of miscarriage and stillbirth rates, there is still much 
uncertainty.  Four of the studies that were included in this systematic review, all 
demonstrate a positive dose-response related effect on caffeine and negative pregnancy 
outcomes.  There was only one study that did not show a relationship between caffeine 
and miscarriages or stillbirths.   
The Grading of Recommendations Assessment, Development and Evaluation 
(GRADE) Working Group was first established in 2000 in order to develop a systematic 
approach for grading the quality of evidence found in studies and the strength of their 
recommendations while minimizing confusion and bias.  The GRADE working group 
recognizes four levels or types of recommendations based on the quality of the study; 
very low, low, moderate, and high.  The interpretation of each recommendation is as 
follows:  
High = further research is very unlikely to change our confidence in the estimate 
of effect; moderate = further research is likely to have an important impact on our 
confidence in the estimate of effect and may change the estimate; low = further 
research is very likely to have an important impact on our confidence in the 
estimate of effect and is likely to change the estimate; very low = any estimate of 
effect is very uncertain (Guyatt et al., 2008, 926).  
 A discussion about each study, its limitations, strengths, and final results will follow.   
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The first article, “Caffeine Intake During Pregnancy, Late Miscarriage and 
Stillbirth,” was a well performed cohort study that identified a positive correlation 
between caffeine intake during pregnancy and late miscarriages and stillbirths 
(Greenwood et al., 2010).  The authors of this study strived to improve their methodology 
by using a highly detailed caffeine assessment tool to identify all dietary sources of 
caffeine including beverages, food, and medications; gaining information prospectively 
rather than retrospectively; and adequately adjusting and correcting for potential 
confounders, most importantly alcohol and tobacco use.  Daily caffeine intake was 
divided into 4 categories; less than 100 mg, 100-199 mg, 200-299 mg, and greater than 
300 mg.  These 4 categories cover a wide range of intake amounts that make it possible to 
better assess a correlation between intake and fetal death.  Despite all of this, there are 
several biases that may have had an impact on the results of the study.  These biases 
include; imprecise estimation of caffeine intake as well as alcohol consumption and 
tobacco use, or inadequate control for important confounding factors.  Retrospective data 
was collected for intake that occurred at four weeks prior to pregnancy and at weeks one 
to four which adds to miscalculations of caffeine consumption.  This study also did not 
address women with different CYP1A2 genes, which affect the rate of caffeine 
metabolism.   
Due to the small study size and few numbers of miscarriages and stillbirths, the 
confidence intervals are wide for the estimated effects.  Therefore, even though the 
results are statistically significant it is hard to determine the exact magnitude of 
association between caffeine intake and miscarriages or stillbirths.  Due to ethical and 
moral reasons, a randomized controlled trial would not be feasible therefore much 
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information has been gained with this study (Greenwood et al., 2010).  This cohort study 
was well designed and executed.  All sources of caffeine were addressed and all potential 
confounders were assessed and adjusted for.  The magnitude of effect, the positive dose-
response that was seen, and the overall quality of the study make this a high quality 
study.     
The second article, “Maternal Caffeine Consumption During Pregnancy and the 
Risk of Miscarriage: A Prospective Cohort Study,” also identified a positive correlation 
between caffeine intake during pregnancy and late miscarriages and stillbirths (Weng et 
al., 2008).  The limitations that were present in this study were numerous.  The study size 
was small with only 1,063 women participating, again making confidence intervals quite 
large.  The participants were asked only about caffeine consumption based on beverages; 
coffee, tea, caffeinated soda, and hot chocolate.  No information was gathered on foods 
and medications that contain caffeine which results in an under reporting of the actual 
amount of caffeine consumed.  This study used conversion factors to calculate the 
amount of caffeine given the source and amount provided by the participant.  But 
miscalculations of caffeine intake are probable as different brands and different brewing 
methods produce differing amounts of caffeine.  Women were then divided into three 
groups based on daily caffeine consumption and yet there was some overlap between the 
groups; 0mg,    0-200mg, and 200+ mg.  This allows for miscalculations as some women 
may have been included in multiple groups.  There was some retrospective information 
collected as women reported caffeine intake from the time of their last menstrual period.  
There is some concern about potential recall bias as 59% of the total miscarriages had 
already occurred at the time of initial contact due to early recruitment.  These women 
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were interviewed soon after their miscarriage, with a median delay of 19 days, and so a 
bias about their consumption could be present as these women had just gone through a 
great emotional event.  The purpose of this study was to examine the effects of caffeine 
intake on miscarriages, which was defined as a fetal death that occurred at or before 20 
weeks’ gestation.  No outcomes after 20 weeks were assessed in this study and so 
additional fetal deaths may and probably did occur after the study period that would have 
lead to additional incidents.   
There were positive aspects to this study that helped to strengthen its final results 
and recommendations.  The early recruitment of women resulted in the in-person 
interview being conducted soon after the pregnancy was confirmed.  This helped to 
reduce the amount of retrospective information that had to be collected.  Not only were 
the participants asked about current caffeine intake, there were also asked about changes 
in consumption once their pregnancy had been confirmed.  Potential confounders, such as 
maternal age, race, education, household income, marital status, smoking, alcohol intake, 
hot tub use, nausea and vomiting, and magnetic field exposure were all included into the 
statistical analysis.  There was no change in the end results when nausea, vomiting, 
aversion to caffeine, smoking, and changes in consumption rates were adjusted for (Weng 
et al., 2008).  Although there were several limitations, this was a well executed cohort 
study which demonstrated a positive dose-response after adjustments were made for all 
potential confounders..   
The article, “Caffeine and Miscarriage Risk,” was the only study to show no 
association between caffeine intake and miscarriage risk (Savitz et al., 2008).  Caffeine 
intake and risk of miscarriage were assessed at three separate time periods, and it was 
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determined that there was no link during any of these time points.  This study had the 
greatest number of limitations that decreased the reliability of the results.  This study 
again looked at miscarriage rates at or before 20 weeks’ gestation, again limiting the total 
number of fetal deaths that may have occurred.  Misclassification of coffee and caffeine 
intake could be present as information about caffeine from chocolate or medications was 
not obtained.  Women were asked about the number of cups of coffee/tea/soda consumed, 
yet the sizes of cups vary greatly.  The amount of caffeine was then determined via 
conversion tables which also adds to miscalculations.  Women were then divided into 
four groups; 0 mg/day, 0-144.3 mg/day, greater than 144.3 mg/day, and greater than 
273.2 mg/day.  Again, there is some overlap between two of the groups which may allow 
for miscalculations.  The authors of this study noticed a trend; when comparing levels of 
caffeine and coffee intake during pregnancy, women who were interviewed after their 
miscarriage reported elevated levels compared with women who experienced their loss 
after the interview.  The elevated intake could be a result of recall bias or true differences.   
 The median caffeine intake by the participants was much less when compared to 
the other studies in this systematic review.  Median caffeine intake was measured at 350 
mg/day prior to and early in pregnancy, and 200 mg/day at the time of interview.  This 
prevented the study from examining the possible effects at 300+ mg/day.   The study 
population may have been more health conscious than those in previous studies because 
the authors enrolled volunteers who sought out prenatal care early or were planning a 
pregnancy.   
There were strengths to this study which consisted of identifying and adjusting for 
potential confounders including; maternal age, race/ethnicity, education, marital status, 
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income, smoking, alcohol use, body mass index, age of menarche, employment status, 
diabetes, miscarriage history, induced abortion history, vitamin use, and nausea and 
vomiting in early pregnancy.  Adjustments for nausea and vomiting did not affect the 
measures of association between coffee or caffeine and miscarriage risk (Savitz et al., 
2008).  Overall, this was a poorly performed cohort study due to the numerous limitations 
that were identified as well as a poor study design and methods.  Although the study’s 
results demonstrate no association between caffeine intake and negative pregnancy 
outcomes, the poor quality of the study reduces its level of recommendations.   
The article, “Coffee and Fetal Death: A Cohort Study with Prospective Data, “was 
the largest study in this systematic review with 88,482 participants (Bech et al., 2005).  
This study again produced results which associated caffeine to miscarriages and 
stillbirths.  Consuming over 8 cups of coffee per day was associated with 1.5 times of the 
risk of fetal death when compared to women with no caffeine consumption.   
There were several limitations present in this study.  This Danish National Birth 
Cohort was not intended to be a representative sample but to be a large source of 
information.  Women were asked about daily consumption of coffee, tea, and caffeinated 
soft drinks.  There was no information obtained about foods, medications, and drinks 
containing chocolate.  The authors used conversion factors to best determine the amount 
of caffeine in a cup of each beverage but differences in caffeine content are seen 
depending on cup size, brand, and brewing method, all leading to possible 
miscalculations.  
Coffee drinking is often associated with other lifestyle factors, such as tobacco 
and alcohol use.  This study adjusted for a large number of factors but uncontrolled 
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confounding factors cannot be ruled out.  However, the authors of this study feel that 
other uncontrolled confounders would need to be strong in order to explain the results.  
Information on potential confounders, such as previous fetal death, parity, smoking, 
alcohol intake, height, pre-pregnancy body weight, and socio-occupational status, were 
obtained and adjustments were made for these factors.   
 Another limitation identified is the lack of information on early nausea and coffee 
aversion.  Nausea is associated with healthy and viable pregnancies as hormonal changes 
necessary for pregnancy cause these symptoms.  Many women with nausea may reduce 
their caffeine more than women not experiencing nausea.  Some believe that coffee 
intake remains high in high risk pregnancies, due to the lack of nausea, and therefore 
caffeine ultimately does not contribute to the fetal demise (Bech et al, (2005).  Overall, 
this was a well performed cohort study based on the quality of this study, the large 
magnitude, and positive dose-response that was seen. 
The final article in this systematic review is titled, “Maternal Caffeine 
Consumption and Fetal Death: a Case-control Study in Uruguay.”  This was the only 
case-control study in this systematic review.  This study again demonstrated a positive 
correlation between caffeine consumption and the increase risk of fetal death 
(Matijasevich et al., 2006).  This study demonstrates that consuming more than 300 mg 
of caffeine a day compared with no caffeine is associated with greater than twice the risk 
of fetal death.  This study had numerous limitations which would have decreased the 
validity of its findings.  The rates of fetal death are much higher in Uruguay compared to 
the United States as access to medical care is less available and medical technology is 
less advanced.  Therefore it is more difficult to associate the fetal deaths to caffeine 
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consumption alone.  In South America, the main sources of caffeine are coffee and mate 
drinking.  Therefore this study used only these two sources to estimate daily caffeine 
intake.  Women were asked about method of preparation, size of the serving, and strength 
of preparation in order to estimate the amount of caffeine for each beverage.  Information 
on other dietary sources was not obtained and as a result caffeine intake may well be 
underestimated.   
This study divided women into 2 groups, control and case groups.  The controls 
were women who conceived healthy and viable newborns.  Women who had a medically 
confirmed diagnosis of spontaneous fetal death were classified into the case group.  No 
miscarriages were assessed in this study, only information on stillbirths or live births 
were obtained.  When comparing maternal characteristics between the two groups, there 
were many differences which could have impacted the results of this study.  Women in 
the case group were more likely to be single mothers, to have a lower income and lower 
educational level, to be younger, tobacco users, experience more nausea and vomiting, 
and to have a history of adverse pregnancy outcomes when compared to the control 
group.   
Specially trained personnel interviewed the women at approximately 24 hours 
after the delivery, which may have had an impact on recall in both the control and case 
groups.  The authors feel that the women may have miscalculated their caffeine, alcohol 
or tobacco use.  This was the only study to obtain information retrospectively that also 
adds to miscalculations.  
There were strengths in this case-control study.  Potential confounders were 
assessed and were adjusted for in the statistical analysis of the data.  Confounders 
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included; family income, marital status, and maternal and partner’s education, maternal 
history of abortion and/or fetal death, smoking and caffeine intake during pregnancy, 
vomiting or nausea during the first trimester of gestation, and attendance in prenatal care 
classes.  After controlling for all potential confounders, high caffeine intake still 
remained associated with increases in fetal death rates (Matijasevich et al., 2006). 
Overall, this was a well performed case-control study which demonstrated a positive 
dose-response association between caffeine intake and fetal death.   
The GRADE table for this systematic review compared pregnant females with no 
caffeine intake to those who consumed caffeine on a daily basis.  Ideally, this GRADE 
table would have looked at specific amounts of caffeine intake per day but each study 
looked at different levels of caffeine consumption.  Therefore this GRADE table 
compared caffeine intake to no caffeine intake.  The purpose of this systematic review 
was to determine the effects of caffeine consumption on two outcomes; females having a 
live and healthy newborn versus having a miscarriage.  The starting GRADE is low as 
each study involved was an observational study.  The findings of the studies involved 
differ as four of the studies show an increase in miscarriage rates with increased caffeine 
consumption.  Only one study shows no correlation between caffeine and fetal deaths.  
Therefore the GRADE cannot be increased for a large magnitude effect or a dose-
response and so it remains a low GRADE recommendation.  If the one study was not 
included in this systematic review, the GRADE would have been increased in both of 
these categories to a moderate level.  The GRADE score was increased in only one 
category, confounders.  All five studies indentified, discussed, and factored the potential 
confounding factors into the statistical analysis.  No major changes in the results were 
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identified after the confounders were adjusted for.  This finding demonstrates that the 
results obtained were based on the relationship between the comparison (caffeine vs. no 
caffeine) and the outcome (healthy birth vs. miscarriage).  The final GRADE is moderate 
which is defined as the following by the GRADE Working Group:.”   
further research is likely to have an important impact on our confidence in the 
estimate of effect and may change the estimate” (Guyatt et al., 2008, 926). 
After reviewing the five articles in this systematic review, the recommendation to 
cease caffeine consumption during pregnancy to decrease the risk of miscarriage or still 
birth is moderate.     
A systematic review of the literature was performed in order to determine the 
effects of caffeine consumption during pregnancy and the risk of miscarriage or stillbirth.  
The final results of this systematic review still remain inconclusive after five studies were 
reviewed in their entirety.  It is recommended that additional studies be conducted in 
order to gain supplementary information.  Due to ethical and moral concerns, a 
randomized controlled trial cannot be conducted in this situation.  It will be up to future 
cohort and case-control studies that are well performed and properly conducted to gain 
the data necessary to finally make a recommendation on this topic.    
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Appendix A 
Table 1.  Late miscarriage and stillbirth rates based on caffeine intake over first trimester 
Caffeine (mg/day) Number of fetal 
deaths 
Adjusted Odds 
Ratio* 
(95% Confidence 
Interval) 
<100 6/998 1.0  
100-199 7/656 2.2 (0.7-7.1) 
200-299 3/402 1.7 (0.4-7.1) 
300 + 9/426 5.1 (1.6-16.4) 
*Adjusted odds ratio by maternal age, parity, tobacco intake, alcohol intake.   
(Greenwood et al., 2010)  
 
 
 
 
 
Table 2.  Risk of miscarriage occuring at or before 20 weeks’ gestation based on caffeine 
intake  
Caffeine 
(mg/day) 
Number of 
Miscarriages 
 (%) 
Number of 
Non- 
Miscarriages 
(%) 
Adjusted 
Hazard 
Ratio* 
(95% 
Confidence 
Ratio) 
0 33 (12.50) 231 (87.50) 1  
<200 97 (15.30) 538 (84.72) 1.42 (0.93-2.15) 
>200 42 (25.45) 122 (74.39) 2.23 (1.34-3.69) 
*Adjusted hazard ratio based on maternal age, education, family income, marital status, 
previous miscarriage, nausea and vomiting since last menstrual period, smoking status, 
alcohol intake, Jacuzzi use, exposure to magnetic fields. 
(Weng et al., 2008) 
 
 
 
 
 
 
Table 3.  Risk of miscarriage occurring at or before 20 weeks’ gestation based on caffeine 
consumption 
Caffeine (mg/day) Number of 
Miscarriages 
Adjusted Odds 
Ratio* 
(95% Confidence 
Interval) 
0 102 1.0  
1 - < 144.3 71 1.0 (0.7-1.4) 
>_144.3 84 1.2 (0.9-1.7) 
>273.2 46 1.3 (0.9-1.9) 
*Adjusted odds ratio for maternal age, race/ethnicity, maternal education, marital status, 
alcohol intake, vitamin use, nausea and vomiting. 
(Savitz et al., 2008) 
 
35 
 
Appendix B 
Table 4.  Fetal death rates based on coffee consumption 
Cups of Coffee 
(cups/day) 
Number of Deaths Adjusted Hazard 
Ratio* 
(95% Confidence 
Interval) 
0 561 1.0  
½-3 307 1.03 (0.89-1.19) 
4-7  130 1.33 (1.08-1.63) 
8 + 60 1.59 (1.19-2.13) 
*Adjusted hazard ratio for maternal age, parity, smoking, prepregnancy body mass index, 
alcohol intake, sociooccupational status. 
(Bech et al., 2005) 
 
 
 
 
 
Table 5.  Fetal death rates based on differing amounts of caffeine consumption 
Mean Caffeine (mg/day) Adjusted Odds Ratio* (95% Confidence Interval) 
0 1.0  
1-59 0.74 (0.42-1.31) 
60-149 0.93 (0.51-1.67) 
150-299 1.22 (0.69-2.17) 
300+ 2.33 (1.23-4.41) 
*Adjusted odds ratio based on maternal and paternal education, history of abortions 
and/or fetal death, vomiting and nausea, prenatal care. 
(Matijasevich et al., 2006) 
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Appendix C 
Table 6.  GRADE Table 
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Caffeine 
consumption 
vs. no 
caffeine 
consumption 
during 
pregnancy  
Live Births 4 
cohort,  
1 case 
control  
Decreased 
live births in 
4 studies.  
No  
relation in 1 
study 
Low 0 0 0 0  0  0 0 +1 Moderate  
 
 
 
 
 
Moderate Miscarriages  4 
cohort,  
1 case 
control 
Increased 
miscarriage 
rates in 4 
studies.  No 
relation in 1 
study.    
Low 0 0 0 0  0 0 0 +1 Moderate 
